Correlation Between Bank of America and Jasper Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and Jasper Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Jasper Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Jasper Therapeutics, you can compare the effects of market volatilities on Bank of America and Jasper Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Jasper Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Jasper Therapeutics.

Diversification Opportunities for Bank of America and Jasper Therapeutics

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bank and Jasper is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Jasper Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jasper Therapeutics and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Jasper Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jasper Therapeutics has no effect on the direction of Bank of America i.e., Bank of America and Jasper Therapeutics go up and down completely randomly.

Pair Corralation between Bank of America and Jasper Therapeutics

Considering the 90-day investment horizon Bank of America is expected to under-perform the Jasper Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bank of America is 7.07 times less risky than Jasper Therapeutics. The stock trades about -0.33 of its potential returns per unit of risk. The Jasper Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  578.00  in Jasper Therapeutics on November 29, 2024 and sell it today you would earn a total of  2.00  from holding Jasper Therapeutics or generate 0.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bank of America  vs.  Jasper Therapeutics

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bank of America has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Jasper Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Jasper Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Bank of America and Jasper Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and Jasper Therapeutics

The main advantage of trading using opposite Bank of America and Jasper Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Jasper Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will offset losses from the drop in Jasper Therapeutics' long position.
The idea behind Bank of America and Jasper Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.